TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
TargetNeuropeptide Y receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
TargetAlpha-1A adrenergic receptor(Homo sapiens (Human))
New York University Medical Center
Curated by ChEMBL
New York University Medical Center
Curated by ChEMBL
Affinity DataKi: 0.229nMAssay Description:Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
TargetAlpha-1A adrenergic receptor(Homo sapiens (Human))
New York University Medical Center
Curated by ChEMBL
New York University Medical Center
Curated by ChEMBL
Affinity DataKi: 0.347nMAssay Description:Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
TargetNeuropeptide Y receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
TargetAlpha-1A adrenergic receptor(Homo sapiens (Human))
New York University Medical Center
Curated by ChEMBL
New York University Medical Center
Curated by ChEMBL
Affinity DataKi: 0.525nMAssay Description:Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
TargetNeuropeptide Y receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
TargetNeuropeptide Y receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
TargetNeuropeptide Y receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
TargetNeuropeptide Y receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
TargetAlpha-1A adrenergic receptor(Homo sapiens (Human))
New York University Medical Center
Curated by ChEMBL
New York University Medical Center
Curated by ChEMBL
Affinity DataKi: 1nMAssay Description:Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorMore data for this Ligand-Target Pair
TargetAlpha-1A adrenergic receptor(Homo sapiens (Human))
New York University Medical Center
Curated by ChEMBL
New York University Medical Center
Curated by ChEMBL
Affinity DataKi: 1nMAssay Description:Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorMore data for this Ligand-Target Pair
TargetAlpha-1A adrenergic receptor(Homo sapiens (Human))
New York University Medical Center
Curated by ChEMBL
New York University Medical Center
Curated by ChEMBL
Affinity DataKi: 1.10nMAssay Description:Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorMore data for this Ligand-Target Pair
TargetAlpha-1A adrenergic receptor(Homo sapiens (Human))
New York University Medical Center
Curated by ChEMBL
New York University Medical Center
Curated by ChEMBL
Affinity DataKi: 1.10nMAssay Description:Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorMore data for this Ligand-Target Pair
TargetAlpha-1A adrenergic receptor(Homo sapiens (Human))
New York University Medical Center
Curated by ChEMBL
New York University Medical Center
Curated by ChEMBL
Affinity DataKi: 1.20nMAssay Description:Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
TargetAlpha-1A adrenergic receptor(Homo sapiens (Human))
New York University Medical Center
Curated by ChEMBL
New York University Medical Center
Curated by ChEMBL
Affinity DataKi: 1.40nMAssay Description:Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorMore data for this Ligand-Target Pair
TargetAlpha-2A adrenergic receptor(Homo sapiens (Human))
Lundbeck Research USA, Inc.
Curated by ChEMBL
Lundbeck Research USA, Inc.
Curated by ChEMBL
Affinity DataKi: 1.40nMAssay Description:Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
TargetAlpha-1A adrenergic receptor(Homo sapiens (Human))
New York University Medical Center
Curated by ChEMBL
New York University Medical Center
Curated by ChEMBL
Affinity DataKi: 1.5nMAssay Description:Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
TargetNeuropeptide Y receptor type 2(Homo sapiens (Human))
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database
Synaptic Pharmaceutical Corporation
Curated by PDSP Ki Database